Gene expression profiling for the identification of G-protein coupled receptors in human platelets.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Thrombosis Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.THROMRES.2007.08.014PMID 17920662
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human platelets express the synaptic markers VGLUT1 and 2 and release glutamate following aggregation.

  2006cited by this paper
• GPR92 as a New G12/13- and Gq-coupled Lysophosphatidic Acid Receptor That Increases cAMP, LPA5*

  2006cited by this paper
• Lysophosphatidic Acid Binds to and Activates GPR92, a G Protein-Coupled Receptor Highly Expressed in Gastrointestinal Lymphocytes

  2006cited by this paper
• Residual platelet ADP reactivity after clopidogrel treatment is dependent on activation of both the unblocked P2Y1 and the P2Y12 receptor and is correlated with protein expression of P2Y12

  2006cited by this paper
• Molecular Pharmacological Phenotyping of EBI2

  2006cited by this paper
• The Variability of Platelet Response to Aspirin and Clopidogrel: Revisiting the Caprie, Cure, Credo, and Match Trials

  2005cited by this paper
• REVIEW ARTICLES: Platelet G protein‐coupled receptors in hemostasis and thrombosis

  2005cited by this paper
• The Human Platelet Membrane Proteome Reveals Several New Potential Membrane Proteins*S

  2005cited by this paper
• Platelet secretory mechanisms.

  2004cited by this paper
• Central role of the P2Y12 receptor in platelet activation.

  2004cited by this paper
• Integration of Proteomics and Genomics in Platelets

  2004cited by this paper
• Novel role of the membrane-bound chemokine fractalkine in platelet activation and adhesion.

  2004cited by this paper
• Role of protease‐activated and ADP receptor subtypes in thrombin generation on human platelets

  2004cited by this paper
• Platelet ADP receptors contribute to the initiation of intravascular coagulation.

  2004cited by this paper
• Gene expression analysis in platelets from a single donor: evaluation of a PCR-based amplification technique.

  2004cited by this paper
• Signaling receptors on platelets and megakaryocytes.

  2004cited by this paper
• Proteomics techniques and their application to hematology.

  2004cited by this paper
• The G protein-coupled receptor repertoires of human and mouse

  2003cited by this paper
• Quantification of ADP and ATP receptor expression in human platelets

  2003cited by this paper
• Identification of p2y9/GPR23 as a Novel G Protein-coupled Receptor for Lysophosphatidic Acid, Structurally Distant from the Edg Family*

  2003cited by this paper
• Signaling events underlying thrombus formation

  2003cited by this paper
• Characterization of platelet-specific mRNA by real-time PCR after laser-assisted microdissection

  2003cited by this paper
• BLT1 and BLT2: the leukotriene B(4) receptors.

  2003cited by this paper
• Messenger RNA profiling of human platelets by microarray hybridization

  2003cited by this paper
• GPCRDB information system for G protein-coupled receptors

  2003cited by this paper
• Transcript profiling of human platelets using microarray and serial analysis of gene expression.

  2003cited by this paper
• Effects of oxytocin and prostaglandin F(2alpha) (enzaprost) on platelet aggregation.

  2002cited by this paper
• Effects of Oxytocin and Prostaglandin F2a (Enzaprost) on Platelet Aggregation

  2002cited by this paper
• Target validation of G-protein coupled receptors.

  2002cited by this paper
• A new mathematical model for relative quantification in real-time RT-PCR.

  2001cited by this paper
• Identification of lysophospholipid receptors in human platelets: the relation of two agonists, lysophosphatidic acid and sphingosine 1‐phosphate

  2000cited by this paper
• Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A(2B) adenosine receptors.

  2000cited by this paper
• Dose and time effects of caffeine intake on human platelet adenosine A(2A) receptors : functional and biochemical aspects.

  2000cited by this paper
• Platelet Adhesion to Native Type I Collagen Fibrils

  1998cited by this paper
• Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow.

  1998cited by this paper
• Effects of serotonin on platelet activation in whole blood

  1997cited by this paper
• Signaling through G Proteins in Platelets: to the Integrins and Beyond

  1997cited by this paper
• NMDA Receptors Play an Anti-aggregating Role in Human Platelets

  1996cited by this paper
• Heterogeneity of the aggregation response of human platelets to arginine vasopressin

  1995cited by this paper
• 2-Alkynyl derivatives of adenosine-5'-N-ethyluronamide: selective A2 adenosine receptor agonists with potent inhibitory activity on platelet aggregation.

  1994cited by this paper
• Inhibition of platelet aggregation by adenosine receptor agonists

  1994cited by this paper
• The Platelet Glycoprotein IIb/IIIa Complex Is lnvolved in the Adhesion of Activated Platelets to Leukocytes

  1993cited by this paper
• Mechanisms of platelet activation: thromboxane A2 as an amplifying signal for other agonists.

  1991cited by this paper
• Platelet thrombus formation on collagen type I. A model of deep vessel injury. Influence of blood rheology, von Willebrand factor, and blood coagulation.

  1988cited by this paper
• Studies on Platelets of Patients with Inherited Platelet Disorders Suggest that Collagen-Induced Fibrinogen Binding to Membrane Receptors Requires Secreted ADP but Not Released α-Granule Proteins

  1985cited by this paper
• 5′‐N‐ETHYLCARBOXAMIDOADENOSINE: A POTENT INHIBITOR OF HUMAN PLATELET AGGREGATION

  1981cited by this paper

• ER-associated degradation pathway protein SEL1L plays an evolutionarily conserved role in platelet adhesion

  2026cites this paper
• Class A Orphans in GtoPdb v.2025.1

  2025cites this paper
• Class A Orphans in GtoPdb v.2025.4

  2025cites this paper
• Lysophospholipid (LPA) receptors in GtoPdb v.2025.3

  2025cites this paper
• New Gene Targets for Diagnosis and Therapy of Diabetic Retinopathy

  2025cites this paper
• Nonclassical Cannabinoid Receptors: Modern Concepts of Signal Transmission Functions and Mechanisms

  2025cites this paper
• Identification of the role of SEL1L in platelet function through a multi-species genetic investigation

  2025cites this paper
• The DNA repair factor ku80 binds and activates the adhesion receptor ELTD1/ADGRL4.

  2025cites this paper
• Lysophospholipid (LPA) receptors in GtoPdb v.2023.1

  2023cites this paper
• The 5-HT_1F receptor as the target of ditans in migraine — from bench to bedside

  2023cites this paper
• Exploration of LPS2 agonist binding modes using the combination of a new hydrophobic scaffold and homology modeling.

  2023cites this paper
• Emerging roles of lysophosphatidic acid receptor subtype 5 (LPAR5) in inflammatory diseases and cancer.

  2023cites this paper
• Effects of Oxysterols on Immune Cells and Related Diseases

  2022cites this paper
• A method based on plateletpheresis to obtain functional platelet, CD3 + and CD14 + matched populations for research immunological studies

  2022cites this paper
• Isoquinolone derivatives as lysophosphatidic acid receptor 5 (LPA5) antagonists: Investigation of structure-activity relationships, ADME properties and analgesic effects.

  2022cites this paper
• Prioritizing Pesticides of Potential Concern and Identifying Potential Mixture Effects in Great Lakes Tributaries Using Passive Samplers

  2022cites this paper
• Integrated analyses of the methylome and transcriptome to unravel sex differences in the perirenal fat from suckling lambs

  2022influential citation
• Lysophospholipid (LPA) receptors in GtoPdb v.2021.2

  2021cites this paper
• Targeted Gene Candidates for Treatment and Early Diagnosis of Age-Related Macular Degeneration

  2021cites this paper
• Role of Cardiac A2A Receptors Under Normal and Pathophysiological Conditions

  2021cites this paper
• Class A Orphans in GtoPdb v.2021.3

  2021cites this paper
• A new trauma frontier: Exploratory pilot study of platelet transcriptomics in trauma patients

  2021cites this paper
• Platelet inhibition by P2Y12 antagonists is potentiated by adenosine signalling activators

  2021cites this paper
• Synthesis and evaluation of adenosine derivatives as A1, A2A, A2B and A3 adenosine receptor ligands containing boron clusters as phenyl isosteres and selective A3 agonists.

  2021cites this paper
• Adenosine Kinase: An Epigenetic Modulator in Development and Disease.

  2021cites this paper
• Efficacy and Effect of Inhaled Adenosine Treatment in Hospitalized COVID-19 Patients

  2021cites this paper
• The role of the CCL25-CCR9 axis in beta-cell function: potential for therapeutic intervention in type 2 diabetes.

  2020cites this paper
• Biased signalling in platelet G-protein-coupled receptors.

  2020cites this paper
• A journey upstream: Fluctuating platelet-specific genes in cell-free plasma as proof-of-concept for using ribonucleic acid sequencing to improve understanding of postinjury platelet biology

  2020cites this paper
• Lysophospholipid (S1P) receptors (version 2020.5) in the IUPHAR/BPS Guide to Pharmacology Database

  2020cites this paper
• Xenotropic and polytropic retrovirus receptor 1 regulates procoagulant platelet polyphosphate.

  2020cites this paper
• Small-Molecule Lysophosphatidic Acid Receptor 5 (LPAR5) Antagonists: Versatile Pharmacological Tools to Regulate Inflammatory Signaling in BV-2 Microglia Cells

  2019cites this paper
• Adenosine and the Cardiovascular System

  2019cites this paper
• Adenosine as a marker and mediator of cardiovascular homeostasis: a translational perspective.

  2019cites this paper
• Blood Platelet Adenosine Receptors as Potential Targets for Anti-Platelet Therapy

  2019cites this paper
• Lysophosphatidic acid and its receptors: pharmacology and therapeutic potential in atherosclerosis and vascular disease.

  2019cites this paper
• Blood platelet surface receptor genetic variation and risk of thrombotic episodes.

  2019cites this paper
• Adenosine and Forskolin Inhibit Platelet Aggregation by Collagen but not the Proximal Signalling Events

  2019cites this paper
• Peripheral serotonin causes dengue virus-induced thrombocytopenia through 5HT2 receptors.

  2019cites this paper
• Lysophospholipid (LPA) receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• Class A Orphans (version 2019.5) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• Lysophospholipids in laboratory medicine

  2018cites this paper
• Production of extracellular lysophosphatidic acid in the regulation of adipocyte functions and liver fibrosis

  2018cites this paper
• Adenosine A2A receptor agonists with potent antiplatelet activity

  2018cites this paper
• Defining G protein-coupled receptor peptide ligand expressomes and signalomes in human and mouse islets

  2018cites this paper
• Identifying Signalling Pathways Regulated by GPRC5B in β-Cells by CRISPR-Cas9-Mediated Genome Editing

  2018cites this paper
• Biology of Platelet Purinergic Receptors and Implications for Platelet Heterogeneity

  2018cites this paper
• EBI2 in splenic and local immune responses and in autoimmunity

  2018cites this paper
• C 3 aR and C 5 aR 1 act as key regulators of human and mouse β ‐ cell function

  2017cites this paper
• C3aR and C5aR1 act as key regulators of human and mouse β-cell function

  2017cites this paper
• Analgesic effects of novel lysophosphatidic acid receptor 5 antagonist AS2717638 in rodents

  2017cites this paper
• A comparative analysis of human and mouse islet G-protein coupled receptor expression

  2017cites this paper
• Studying platelet and monocyte function in atherosclerosis by employing quantitative proteomics

  2017cites this paper
• Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development

  2017cites this paper
• DEVELOPMENT OF PHARMACOLOGICAL TOOLS FOR THE IDENTIFICATION OF G PROTEIN-COUPLED RECEPTORS LIGANDS

  2016cites this paper
• Quantification of the mRNA expression of G protein-coupled receptors in human adipose tissue.

  2016cites this paper
• Purinergic signalling in brain ischemia.

  2016cites this paper
• Insight into SUCNR1 (GPR91) structure and function.

  2016cites this paper
• Normalization of qPCR in platelets – YWHAE a potential genericreference gene

  2016cites this paper
• The Role of the Oxysterol/EBI2 Pathway in the Immune and Central Nervous Systems.

  2016cites this paper
• Putative duality of presynaptic events

  2016cites this paper
• Blood cells: an historical account of the roles of purinergic signalling

  2015cites this paper
• Manipulating integrin signaling for anti-thrombotic benefits

  2015cites this paper
• LPA receptor signaling: pharmacology, physiology, and pathophysiology

  2014cites this paper
• Characterisation of human airway smooth muscle cell lysophosphatidic acid receptors in asthma and health

  2014cites this paper
• Identification of drug-induced myocardial infarction-related protein targets through the prediction of drug-target interactions and analysis of biological processes.

  2014cites this paper
• Adenosine receptors in cerebral ischemia.

  2014cites this paper
• Serotonin dynamics in and around the central nervous system: Is autism solvable without fundamental insights?

  2014cites this paper
• Lysophospholipid receptor nomenclature review: IUPHAR Review 8

  2014cites this paper
• Vascular adenosine receptors; potential clinical applications.

  2013cites this paper
• Platelets activated during myocardial infarction release functional miRNA which can be taken up by endothelial cells and regulate ICAM1 expression

  2013cites this paper
• Lysophosphatidic Acid (LPA) Signaling and Cardiovascular Pathology

  2013cites this paper
• Autotaxin and lysophosphatidic acid signalling in lung pathophysiology

  2013cites this paper
• Overview of Nonclassical Cannabinoid Receptors

  2013cites this paper
• Clinical and Biological Aspects of Cardiovascular microRNA

  2013cites this paper
• Current progress in non-Edg family LPA receptor research.

  2013cites this paper
• Lysophosphatidic Acid (LPA) Receptor Signaling

  2013cites this paper
• Expression of G-protein Coupled Receptors in Young and Mature Thrombocytes and Knockdown of Gpr18 in Zebrafish

  2013cites this paper
• Identification of Multiple Levels of Trauma Induced Coagulopathy

  2013cites this paper
• Targeting Platelet G Protein‐Coupled Receptors for Antithrombotic Therapy

  2013cites this paper
• Validation of Reference Genes for the Determination of Platelet Transcript Level in Healthy Individuals and in Patients with the History of Myocardial Infarction

  2013cites this paper
• Glutamate release from platelets: exocytosis versus glutamate transporter reversal.

  2013cites this paper
• Platelets activated during myocardial infarction release functional miRNA which can regulate

  2013cites this paper
• Lysophosphatidic acid in atherosclerotic diseases

  2012influential citation
• A rapid and efficient platelet purification protocol for platelet gene expression studies.

  2012cites this paper
• Farnesyl pyrophosphate is an endogenous antagonist to ADP-stimulated P2Y12 receptor-mediated platelet aggregation

  2012cites this paper
• Selective non-lipid modulator of LPA5 activity in human platelets.

  2012cites this paper
• Platelet proteomics: state of the art and future perspective.

  2012cites this paper
• Targeting adenosine receptors in the development of cardiovascular therapeutics

  2012cites this paper
• Targeted Deletion of LPA5 Identifies Novel Roles for Lysophosphatidic Acid Signaling in Development of Neuropathic Pain*

  2012cites this paper
• G protein-coupled receptors for energy metabolites as new therapeutic targets

  2012cites this paper
• The impact of glucotoxicity on pancreatic β-cell function

  2012cites this paper
• Ectonucleotide triphosphate diphosphohydrolase-1 (CD39) mediates resistance to occlusive arterial thrombus formation after vascular injury in mice.

  2012cites this paper
• ADP regulation of insulin secretion and beta-cell apoptosis

  2012cites this paper
• Coronary artery bypass graft surgery up‐regulates genes involved in platelet aggregation

  2012cites this paper
• Succinate reverses in-vitro platelet inhibition by acetylsalicylic acid and P2Y receptor antagonists

  2012cites this paper
• On the immunopathogenesis of systemic lupus erythematosus - Immune complexes, type I interferon system, complement system and platelets

  2012cites this paper
• Targeted Deletion of LPA 5 Identifies Novel Roles for Lysophosphatidic Acid Signaling in Development of

  2012cites this paper
• The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways.

  2012cites this paper
• A2 Adenosine Receptors and Vascular Pathologies

  2012cites this paper